Table 1.
Clinicopathological parameters of 91 breast cancer patients
| Parameters | Number (%) |
|---|---|
| Age (years) | |
| ≤50 | 43 (47.3) |
| >50 | 48 (52.7) |
| Pathological type | |
| DCIS | 3 (3.3) |
| IDC | 61 (67.0) |
| ILC | 7 (7.7) |
| Invasive duct-lobular cancer | 2 (2.2) |
| Invasive cancer | 17 (18.7) |
| Others | 1 (1.1) |
| Tumor grade | |
| Grade 1 | 1 (1.1) |
| Grade 2 | 49 (53.8) |
| Grade 3 | 17 (18.7) |
| Unknown | 24 (26.4) |
| ER status | |
| Positive | 65 (71.4) |
| Negative | 26 (28.6) |
| PR status | |
| Positive | 59 (64.8) |
| Negative | 32 (35.2) |
| HER-2 | |
| Positive | 25 (27.5) |
| Negative | 66 (72.5) |
| AJCC stage | |
| 0 | 3 (3.3) |
| I | 10 (11.0) |
| II | 31 (34.1) |
| III | 6 (6.6) |
| IV | 41 (45.1) |
Abbreviations: DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor 2; AJCC, American Joint Committee on Cancer.